Herpes Cure Advocacy Hosts Pipeline 4.0 Release Meeting to Spotlight Breakthroughs in HSV Research - World Patients Alliance

Herpes Cure Advocacy Hosts Pipeline 4.0 Release Meeting to Spotlight Breakthroughs in HSV Research

8 May 2025 – Virtual

Herpes Cure Advocacy convened experts, patient advocates, and research stakeholders for the Pipeline 4.0 Release Meeting, a virtual event showcasing the latest developments in the global search for a cure for herpes simplex virus (HSV).
Held on May 8, 2025, the session marked the release of the Herpes Cure Pipeline 4.0, a proprietary report that maps out active pre-clinical and clinical research efforts focused on HSV-1 and HSV-2. The updated pipeline highlights a wave of promising therapeutic candidates, including mRNA-based vaccines, gene editing technologies, and next-generation antivirals.

Despite HSV affecting billions globally and carrying significant health and economic burdens, the virus remains chronically underfunded in terms of research and innovation. This event aimed to raise awareness, encourage investment, and build community support for accelerating progress toward effective treatments and potential cures.

Key segments of the meeting included:

• A review of recent advances in therapeutic science targeting HSV latency and recurrence
• Analysis of challenges in trial design and regulatory pathways
• A patient-led discussion on lived experience and unmet care needs

Participants also explored how Herpes Cure Advocacy is working to expand the pipeline by connecting funders, researchers, and communities around a unified mission: ending the neglect of herpes research.

The event emphasized that growing scientific momentum must now be matched by political will, funding support, and inclusive research frameworks that prioritize patient needs. As HSV research evolves, so too does the call for collaborative, data-driven strategies to break long-standing silos in infectious disease innovation.